Newbridge Financial Services Group’s Collegium Pharmaceutical COLL Stock Holding History

Newbridge Financial Services Group’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-64	Closed	-$1.43K	–	1199
2023 Q3	$1.43K	Hold	64	–	–	﹤0.01%	1123
2023 Q2	$1.38K	Hold	64	–	–	﹤0.01%	1180
2023 Q1	$1.53K	Hold	64	–	–	﹤0.01%	1237
2022 Q4	$1.49K	Hold	64	–	–	﹤0.01%	1263
2022 Q3	$1K	Hold	64	–	–	﹤0.01%	1278
2022 Q2	$1K	Hold	64	–	–	﹤0.01%	1258
2022 Q1	$1K	Hold	64	–	–	﹤0.01%	1362
2021 Q4	$1K	Sell	64 -4,380	-99%	-$85.4K	﹤0.01%	1308
2021 Q3	$88K	Buy	4,444 +4,380	+6,844%	+$94.7K	0.06%	288
2021 Q2	$2K	Hold	64	–	–	﹤0.01%	1261
2021 Q1	$2K	Buy	+64	New	+$1.52K	﹤0.01%	1161

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Newbridge Financial Services Group's COLL Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of Collegium Pharmaceutical (COLL) in Q4 2023, closing a stake of 64 shares — an estimated $1.43K sold.

Newbridge Financial Services Group first reported a position in COLL in Q1 2021 and held it in 11 quarters. The position peaked at $88K in Q3 2021. 193 funds tracked by Wall St. Rank hold COLL as of Q4 2023.

Newbridge Financial Services Group reported no remaining Collegium Pharmaceutical position as of Q4 2023 after selling out during the quarter.
Newbridge Financial Services Group sold 64 Collegium Pharmaceutical shares in Q4 2023, an estimated $1.43K.
Newbridge Financial Services Group first reported a position in Collegium Pharmaceutical in Q1 2021 and held it in 11 quarters.
Newbridge Financial Services Group's Collegium Pharmaceutical position peaked at $88K in Q3 2021.
193 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.